COMPOUND PHARMACEUTICAL COMPOSITION FOR TREATING SKIN INFLAMMATORY DISEASES

The disclosure relates to the field of pharmaceutical technology, in particular, to a compound pharmaceutical composition for treating skin inflammatory diseases, which is characterized in that an active ingredient of the compound pharmaceutical of the disclosure is composed of tofacitinib and crisa...

Full description

Saved in:
Bibliographic Details
Main Authors Xu, Qinlong, Mo, Jiajia, Bian, Lincui, Chu, Zhaoxing, Shao, Li, Zhao, Yan, He, Guangwei, Gu, Yuanfeng
Format Patent
LanguageEnglish
Published 12.11.2020
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The disclosure relates to the field of pharmaceutical technology, in particular, to a compound pharmaceutical composition for treating skin inflammatory diseases, which is characterized in that an active ingredient of the compound pharmaceutical of the disclosure is composed of tofacitinib and crisaborole, and the composition has a stronger therapeutic effect and a lower dosage with a significant synergistic therapeutic effect. The pharmaceutical composition of the disclosure can be used to treat skin inflammatory diseases.
Bibliography:Application Number: US201916761996